Caroline Palomeque is a Senior Equity Research Analyst focused on the Biotechnology sector within Wall Street sell-side investment banks. In this role, she initiates coverage of numerous Small-to-Large-Cap biotechnology companies across various therapeutic areas.
Palomeque's work involves a comprehensive approach, combining top-down thematic research with bottom-up fundamental analysis. She also utilizes financial modeling to develop Buy/Sell/Hold investment recommendations.